# US 2026/0060237 A1 · Hydrogel Beads for Controlled Uptake and Release of Cryoprotective Agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0060237 A1
- Document ID: US20260060237A1
- Status: Published application
- Kind: A1
- Application number: 19/378,240
- Filed: 2025-11-03
- Published: 2026-03-05
- Earliest claimed: 2020-07-17
- Assignees: The General Hospital Corporation
- Applicants: The General Hospital Corporation
- Inventors: Derin Sevenler; Rebecca Sandlin; Mehmet Toner
- Web page: https://patentgrep.com/patent/US20260060237A1

## CPC

- A01N 1/162: Temperature processes, e.g. following predefined temperature changes over time
- A01N 1/125: Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- C12N 5/0636: {T lymphocytes}
- C12N 2533/74: Alginate
- C12N 2537/10: Cross-linking
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Hydrogel beads having tunable rates of loading and unloading of cryoprotective agents are provided herein. Such hydrogel beads can be dispersed throughout a cell suspension to enable loading and unloading of cryoprotective agents from cells in a gradual and distributed manner that protects the cells from osmotic damage. Lymphocyte viability after cryopreservation is significantly greater when cryoprotective agents are loaded and unloaded using hydrogel beads compared to conventional media exchange methods.

## Claims

### Claim at position 1

1-48. (canceled)

### Claim 49

A hydrogel bead comprising one or more cryoprotective agents, wherein the hydrogel bead has a diameter of 1 to 5 mm.

### Claim 50 (depends on 49)

The hydrogel bead of claim 49, wherein the hydrogel bead is free of cells.

### Claim 51 (depends on 49)

The hydrogel bead of claim 49, wherein the hydrogel bead has a volume of 0.5 to 65 μL.

### Claim 52 (depends on 49)

The hydrogel bead of claim 49, wherein the hydrogel bead has a weight of 0.5 to 65 mg.

### Claim 53 (depends on 49)

The hydrogel bead of claim 49, wherein the one or more cryoprotective agents are present in the hydrogel bead at an amount of 2.5% to 50% (v/v).

### Claim 54 (depends on 49)

The hydrogel bead of claim 49, wherein the one or more cryoprotective agents comprises an intracellular cryoprotective agent, an extracellular cryoprotective agent, or both.

### Claim 55 (depends on 53)

The hydrogel bead of claim 53, wherein the intracellular cryoprotective is selected from the group consisting of glycerol, ethylene glycol, 1,2-propanediol, and dimethyl sulfoxide (DMSO).

### Claim 56 (depends on 53)

The hydrogel bead of claim 53, wherein the extracellular cryoprotective agent is selected from the group consisting of sugars, dextran, polyvinyl pyrrolidone and hydroxyethyl starch.

### Claim 57 (depends on 49)

The hydrogel bead of claim 49, wherein the hydrogel bead comprises a biological polymer, a synthetic polymer, or a combination thereof.

### Claim 58 (depends on 57)

The hydrogel bead of claim 57, wherein the biological polymer comprises dextran, chitosan, alginate, fibrin, collagen, gelatin, or a combination thereof.

### Claim 59 (depends on 57)

The hydrogel bead of claim 57, wherein the synthetic polymer comprises poly(hydroxyethyl methacrylate) (PHEMA), poly(vinyl alcohol) (PVA), poly(ethylene glycol) (PEG), poly(acrylic acid) (PAA), poly(methacrylic acid) (PMMA), and polyacrylamide (PAA).

### Claim 60 (depends on 49)

A composition comprising the hydrogel bead of claim 49.

### Claim 61 (depends on 60)

The composition of claim 60, further comprising a solution comprising one or more cryoprotective agents.

### Claim 62 (depends on 60)

The composition of claim 60, further comprising a preservative.

### Claim at position 16

63-73. (canceled)
